12Th International Congress - Aortic Surgery | Peripheral & Venous "How To Do It"

Dettagli RES

Inizio

16/12/2026

Fine

18/12/2026

Durata (ore)

32

Tipo evento

Congresso/Simposio/Conferenza/Seminario

Rilevanza

Internazionale

Interattivo

No

Luogo

CENTRO CONGRESSI OSPEDALE SAN RAFFAELE, VIA OLGETTINA 58, MILANO, MILANO, LOMBARDIA

Wednesday, December 16th

December 16, 2026

• 08:00–08:06 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — In stent restenosis after drug eluting stent in the superficial femoral artery: plaque morphology comparison between different platform (Gianmarco de Donato)
• 08:06–08:12 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — Lower limb revascularization by means of thrombectomy with specific devices (Stefano Bonvini)
• 08:12–08:18 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — Endovascular PTA and stenting of deep femoral artery lesions is possible and effective (Pasqualino Sirignano)
• 08:18–08:24 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — Prophylactic embolization (Michele Antonello)
• 08:24–08:30 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — When innovation meets real-world challenges in SFA treatment (Daniele Mascia)
• 08:30–08:36 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — Paclitaxel debate: what robust long-term data tell us about drug-coated balloons (Wassim Mansour)
• 08:36–08:42 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — Orbital atherectomy (Felice Pecoraro)
• 08:42–08:50 SESSION 1: PERIPHERAL ARTERIAL DISEASE I — Discussion
• 08:53–08:59 SESSION 2: VENOUS I — A minimally invasive techinique of open saphenectomy. How I do it (Calogero Presti)
• 08:59–09:05 SESSION 2: VENOUS I — Advances in the treatment of venous insufficiency with dense foam sclerotherapy (Frederico Araujo Oliveira)
• 09:05–09:11 SESSION 2: VENOUS I — Choosing between superficial venous interventions in modern venous practice (Manj Gohel)
• 09:11–09:17 SESSION 2: VENOUS I — Is there still a place for open surgery in varicose veins? (Armando Mansilha)
• 09:17–09:23 SESSION 2: VENOUS I — Modern sclerotherapy: what has changed? (Enric Roche)
• 09:23–09:29 SESSION 2: VENOUS I — Foam schleroterapy and the Brasilian Public Health System: Ten years results. (Marcelo Liberato de Moura)
• 09:29–09:35 SESSION 2: VENOUS I — Why polidocanol endovenous microfoam (PEM) is becoming the gold standard treatment modality for symptomatic refluxing superficial veins despite limited long term results (Alexandra Natalie Ascher)
• 09:35–09:42 SESSION 2: VENOUS I — Discussion
• 09:45–09:51 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Oncovascular surgery: role of the vascular surgeon in the treatment of neoplastic lesions (Gian Franco Veraldi)
• 09:51–09:57 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Management of acute mesenteric ischemia with retrograde open mesenteric stenting (Nabil Chakfé)
• 09:57–10:03 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Does omentoasty at index open aortic repair prevent from infection and aortoenteric fistula? (Gabriele Piffaretti)
• 10:03–10:09 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Modern Management of Median Arcuate Ligament Syndrome (MALS) (Benjamin Starnes)
• 10:09–10:15 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Cadaver lab testing in preclinical evaluation of new devices, the key role of skilled independent physicians (Luca Garriboli)
• 10:15–10:21 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Open renal artery reconstructions in endovascular era (Nelson De Luccia)
• 10:21–10:27 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Sac regression during follow-up (Felice Pecoraro)
• 10:27–10:35 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Discussion
• 10:35–10:45 SESSION 3: CRITICAL TOPICS IN ARTERIAL SURGERY — Keynote Lecture: Management of aorto-oesophageal fistula (Aung Oo)
• 10:48–10:54 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Retrospective multicenter study of below the knee revascularization in the absence of saphenous vein: comparison of prosthetic bypass and endovascular treatment (Raffaello Bellosta)
• 10:54–11:00 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Peroneal artery bypass for limb salvage in chronic limb-threatening ischemia: a multicenter 5-year experience (Efrem Civilini)
• 11:00–11:06 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Extreme retrograde punctures (Marta Lobato)
• 11:06–11:12 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Current options for revascularization of the ischemic diabetic foot: what has changed in recent years (Edwaldo Joviliano)
• 11:12–11:18 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Everolimus eluting resorbable scaffold system (Daniele Mascia)
• 11:18–11:25 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Discussion
• 11:25–11:35 SESSION 4: PERIPHERAL ARTERIAL DISEASE II — Keynote Lecture: Distal and ultra distal bypass after failed endo: challenges and solutions (Gonçalo Cabral)
• 11:38–11:44 SESSION 5: VASCULAR EMERGENCIES I — SVS blunt thoracic aortic injury. Clinical practice guidelines 2.0 (Ali Azizzadeh)
• 11:44–11:50 SESSION 5: VASCULAR EMERGENCIES I — Current controversies on blunt aortic trauma (Luís Mendes Pedro)
• 11:50–11:56 SESSION 5: VASCULAR EMERGENCIES I — Blunt traumatic aortic injuries in 2026: when to intervene, when to wait, and how to do it safely (Tania Saez Guzman)
• 11:56–12:02 SESSION 5: VASCULAR EMERGENCIES I — Complex aortic emergencies: from silent killer to surgical success (Orwa Falah)
• 12:02–12:08 SESSION 5: VASCULAR EMERGENCIES I — Long term outcomes and cardiovascular remodeling after TEVAR for blunt thoracic aortic injury (Rabih Chaer)
• 12:08–12:15 SESSION 5: VASCULAR EMERGENCIES I — Discussion
• 12:15–12:25 SESSION 5: VASCULAR EMERGENCIES I — Keynote Lecture: Vascular trauma: An evolution in therapy (Benjamin Starnes)
• 12:28–12:34 SESSION 6: ARTERIAL/CAROTID — Carotid body tumor: San Raffaele experience (Carlotta Bugna)
• 12:34–12:40 SESSION 6: ARTERIAL/CAROTID — From CEA to TCAR to CAS. A high volume surgeon journey on carotid disease over last 20 years (Fernando Gallardo)
• 12:40–12:46 SESSION 6: ARTERIAL/CAROTID — Micromesh stent for CAS (Gianbattista Parlani)
• 12:46–12:52 SESSION 6: ARTERIAL/CAROTID — Are the CREST-2 results reliable to change clinical practice in patients with asymptomatic carotid stenosis? (Armando Mansilha)
• 12:52–12:58 SESSION 6: ARTERIAL/CAROTID — Visceral artery aneurysms: insights from the European Visceral Artery Revascularization (EVisAR) study (Roberto Silingardi)
• 12:58–13:04 SESSION 6: ARTERIAL/CAROTID — Carotid body tumor: hybrid approach (Paolo Frigatti) — Printed as 13.58 in PDF — typo for 12.58
• 13:04–13:10 SESSION 6: ARTERIAL/CAROTID — The endless dilemma in the treatment of asymptomatic carotid disease: did CREST-2 change our paradigm? (Andrea Kahlberg)
• 13:10–13:20 SESSION 6: ARTERIAL/CAROTID — Discussion
• 13:20–13:30 SESSION 6: ARTERIAL/CAROTID — Special Lecture: Priorities in managing a major emergency involving 12 subjects with severe burns (Franz W. Baruffaldi Preis)
• 13:30–14:00 Lunch
• 14:00–14:06 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Results of the arch brave multicenter study for branched zone zero repair (Nikolaos Tsilimparis)
• 14:06–14:12 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — How to deal with arch pathology in high risk patients for open repair (Ruy Fernandes et Fernandes)
• 14:12–14:18 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Stroke prevention in TEVAR: what is the role of air, what are the outcomes of RCTs on carbondioxide flushing and how can a new device help to eliminate the risks associated with air-embolism? (Tilo Kölbel)
• 14:18–14:24 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — 120 carotid-subclavian bypasses - do we consider the subclavian ostium as part of the sealing zone? (Beate Lindberg)
• 14:24–14:30 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — TEVAR in the presence of an aberrant left vertebral artery: planning, pitfalls, and revascularization strategies (Tania Saez Guzman)
• 14:30–14:36 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Total endovascular aortic arch repair with triple branched arch endograft (Giovanni Pratesi)
• 14:36–14:42 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Hybrid arch treatment (Enrico Rinaldi)
• 14:42–14:48 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Early results of fenestrated and branched endovascular repair of complex aortic aneurysms (Mauri Camparin)
• 14:48–14:57 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Discussion
• 14:57–15:07 SESSION 7: ARCH AND THORACO-ABDOMINAL AORTIC ANEURYSM — Keynote Lecture: Total endo arch repair (Stephan Haulon)
• 15:10–15:16 SESSION 8: COMPLEX AORTIC PROCEDURES — Clinical and geometrical results of self-expandable stent grafts for thoraco-abdominal aortic repair (Luca Mezzetto)
• 15:16–15:22 SESSION 8: COMPLEX AORTIC PROCEDURES — Punch, ring, reload, deploy: a pole-position physician-modified endograft workflow (Csaba Csobay-Novák)
• 15:22–15:28 SESSION 8: COMPLEX AORTIC PROCEDURES — Endovascular treatment of abdominal aortic aneurysms with hostile neck using polymer-ring stent grafts (Horatiu Moldovan (Marian Broasca))
• 15:28–15:34 SESSION 8: COMPLEX AORTIC PROCEDURES — Endo arch repair with multifeature endografts; scallop, fenestration and branch to manage complex anatomy (Michele Piazza)
• 15:34–15:40 SESSION 8: COMPLEX AORTIC PROCEDURES — We now have multiple options for TEVAR at left subclavian level. Which should we use and when? (Michael Jenkins)
• 15:40–15:46 SESSION 8: COMPLEX AORTIC PROCEDURES — Open Repair vs branched endovascular aortic repair in residual dissection after Type A surgical repair (Giovanni Tinelli)
• 15:46–15:52 SESSION 8: COMPLEX AORTIC PROCEDURES — Advantages of a semi-custom endograft with low radial force in the treatment of aortic dissections (Paolo Frigatti)
• 15:52–15:58 SESSION 8: COMPLEX AORTIC PROCEDURES — Fenestrated and branched endovascular repair for complex abdominal and thoracoabdominal aneurysms with repositionable devices: technical pearls and pitfalls (Edwaldo Joviliano)
• 15:58–16:07 SESSION 8: COMPLEX AORTIC PROCEDURES — Discussion
• 16:07–16:17 SESSION 8: COMPLEX AORTIC PROCEDURES — Keynote Lecture: How to choose the best option for patients with complex aortic disease (Eric Verhoeven)
• 16:20–16:26 SESSION 9: VENOUS II — DUS imaging in patients with deep venous disease (Marie Josee van Tongerlo - van Rijn)
• 16:26–16:32 SESSION 9: VENOUS II — MRI in pelvic venous insufficiency (Anna Palmisano)
• 16:32–16:38 SESSION 9: VENOUS II — Pelvic venous disease: how I do zonal diagnosis and embolization – From IVUS to coils, glue & hybrid strategies (Marald Wikkeling)
• 16:38–16:42 SESSION 9: VENOUS II — Diagnostic and therapeutic pathways for pelvic venous disorders – A national multidisciplinary consensus (Domenico Baccellieri)
• 16:42–16:48 SESSION 9: VENOUS II — Venotonic drugs for chronic pelvic pain: a systematic review (Monika Gloviczki)
• 16:48–16:54 SESSION 9: VENOUS II — Optimizing circulation through breathing during exercise: clinical changes in patients after two years of follow-up (Rebeca Reachi-Lugo)
• 16:54–17:00 SESSION 9: VENOUS II — Discussion
• 17:00–17:10 SESSION 9: VENOUS II — Keynote Lecture: How to perform pelvic vein embolization and choose the right technique (Gloria Maria Martinez Salazar)
• 17:13–17:19 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Endovascular management of aortoesophageal fistula in a 2 year-old (Erica Mitchell)
• 17:19–17:25 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Treatment of aortic graft/stent graft infections, including the management of infected fenestrated/branched arch/TAAA stent grafts (Anders Wanhainen)
• 17:25–17:31 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Open surgery is the best option in abdominal and thoracic aortic endograft infection (Yamume Tshomba)
• 17:31–17:37 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Neo aortoiliac system: how I do it (James Black)
• 17:37–17:43 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Mycotic aortic aneurysm - current status (James Tunnicliffe)
• 17:43–17:49 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — What is the lifetime outcome for patients undergoing endovascular treatment of aortic interventions and does surveillance matter? Population data from primary care (Michael Jenkins)
• 17:49–17:55 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Open conversion after failed EVAR is safe and effective (Andrea Kahlberg)
• 17:55–18:01 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Hybrid treatment of aorto-iliac occlusive disease (Walter Dorigo)
• 18:01–18:07 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — The role of the anatomical configuration of the lumbar arteries in the progression of the aneurysm sac following standard EVAR (Filippo Benedetto)
• 18:07–18:13 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — How I do it: managing reinterventions after F/BEVAR (Fatima Javairiah)
• 18:13–18:25 SESSION 10: COMPLICATIONS PREVENTION AND MANAGEMENT — Discussion
• 18:28–18:34 SESSION 11: VASCULAR EMERGENCIES II — Xenograft and homograft surgical reconstruction in complicated aortic infections (Valerio Tolva)
• 18:34–18:40 SESSION 11: VASCULAR EMERGENCIES II — Multidisciplinary protocols for acute mesenteric ischemia improve outcomes (Rabih Chaer)
• 18:40–18:46 SESSION 11: VASCULAR EMERGENCIES II — Acute embolic mesenteric ischemia: a vascular emergency (Rudi Stramanà)
• 18:46–18:52 SESSION 11: VASCULAR EMERGENCIES II — Vascular trauma: open and endo resources for a large center (Tayrine Mazotti)
• 18:52–18:58 SESSION 11: VASCULAR EMERGENCIES II — Management of pediatric vascular emergencies. Who will be the caretakers of pediatric vascular trauma? (Erica Mitchell)
• 18:58–19:04 SESSION 11: VASCULAR EMERGENCIES II — Endovascular hemostasis with an occlusive balloon in inferior vena cava lesions (Ricardo Yukio Okawa)
• 19:04–19:10 SESSION 11: VASCULAR EMERGENCIES II — Discussion

Thursday, December 17th

December 17, 2026

• 07:30–07:42 SESSION 12: ROUND TABLE | GENDER ISSUES IN VASCULAR SURGERY — Debate 1 | IS MERITOCRACY ALONE SUFFICIENT IN MODERN SURGICAL LEADERSHIP? YES / NO (Erica Mitchell, Fiona Rohlffs) — Panellists: Alexandra Natalie Ascher, Carlotta Bugna, Mariangela De Masi, Young M. Erben, Tania Saez Guzman, Marta Lobato, Chiara Lomazzi, Irene Morelli, Grace Mulatti, Rebeca Reachi-Lugo, Sonia Ronchey, Simona Zannetti, Dora Z. Zatyko
• 07:42–07:59 SESSION 12: ROUND TABLE | GENDER ISSUES IN VASCULAR SURGERY — Debate 2 | SHOULD GENDER BASED "QUOTAS" BE ENFORCED AT LEAST IN EVENTS FUNDED WITH PUBLIC MONEY? YES / NO + Leadership in different medical specialties (Alice Cabral Lopes, Beate Lindberg, Elena Bignami)
• 08:00–08:10 SESSION 12: ROUND TABLE | GENDER ISSUES IN VASCULAR SURGERY — Panel discussion
• 08:13–08:19 SESSION 13: ARTIFICIAL INTELLIGENCE I — The proof of concept of computational simulation on TEVAR (Santi Trimarchi)
• 08:19–08:25 SESSION 13: ARTIFICIAL INTELLIGENCE I — Prediction of cardiovascular disease progression in AAA patients using AI, the VASCUL-AID platform (Kak Khee Yeung)
• 08:25–08:31 SESSION 13: ARTIFICIAL INTELLIGENCE I — Automated objective metrics processing for training in vascular surgery (Nabil Chakfé)
• 08:31–08:37 SESSION 13: ARTIFICIAL INTELLIGENCE I — Artificial Intelligence in DVT Diagnosis - Changing the standard pathway (Efthymios Avgerinos)
• 08:37–08:43 SESSION 13: ARTIFICIAL INTELLIGENCE I — Advancing aortic care: from advanced imaging to robotic intervention (Dora Z. Zatyko)
• 08:43–08:49 SESSION 13: ARTIFICIAL INTELLIGENCE I — AI applications for aortic procedures, is modern EVAR too complex to be managed with human estimation alone? (Fernando Gallardo)
• 08:49–08:55 SESSION 13: ARTIFICIAL INTELLIGENCE I — IMPROVE-AD gone aritificial: how digital twin will be better in uncomplicated TBAD (Firas F. Mussa)
• 08:55–09:01 SESSION 13: ARTIFICIAL INTELLIGENCE I — Deep learning-driven false-lumen volumes predict adverse remodelling better than diameter in patients with residual aortic dissection CT (Alexis Jacquier)
• 09:01–09:10 SESSION 13: ARTIFICIAL INTELLIGENCE I — Discussion
• 09:10–09:20 SESSION 13: ARTIFICIAL INTELLIGENCE I — Keynote Lecture: Artificial intelligence in trauma care (Elena Bignami)
• 09:23–09:29 SESSION 14: AORTIC DISSECTION — FET in chronic aortic dissection (Alessandro Castiglioni)
• 09:29–09:35 SESSION 14: AORTIC DISSECTION — 5-year results of endosuture aneurysm repair (ESAR) in patients with wide neck AAA from the ANCHOR Registry (Giovanni Pratesi)
• 09:35–09:41 SESSION 14: AORTIC DISSECTION — Update on Type A dissections treatment with the EndoWheat approach (Stephan Haulon)
• 09:41–09:47 SESSION 14: AORTIC DISSECTION — IVUS guided Intervention of malperfusion syndrome in complicated type B or residual Type B aortic dissection (Jimmy Wei Hwa Tan)
• 09:47–09:53 SESSION 14: AORTIC DISSECTION — How to safely perform TEVAR for acute Type B intramural hematoma (Jean Panneton)
• 09:53–09:59 SESSION 14: AORTIC DISSECTION — Strategies for BEVAR in Chronic aortic dissection (Jorge Fernández Noya)
• 09:59–10:05 SESSION 14: AORTIC DISSECTION — Open surgery in chronic Type B aortic dissection (Laurent Chiche)
• 10:05–10:11 SESSION 14: AORTIC DISSECTION — Trends and variations in technique open adjuncts to enhance FBEVAR feasibility failing forward (Bernardo Mendes)
• 10:11–10:20 SESSION 14: AORTIC DISSECTION — Discussion
• 10:20–10:30 SESSION 14: AORTIC DISSECTION — Debate: High risk features may indicate TEVAR in Type B aortic dissection / NO: a CRT is needed (Joseph V. Lombardi, Firas F. Mussa)
• 10:33–10:39 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Clinical experience with a new TAAA system (Stoyan Kondov)
• 10:39–10:45 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — The three-stage approach for the treatment of complex thoraco-abdominal pathology (Martin Czerny)
• 10:45–10:51 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Transradial approach for BEVAR. One year accumulated experience (Nilo Mosquera)
• 10:51–10:57 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Total endovascular aortic repair by F/BEVAR from ascending to infra-renal aorta / iliac arteries (Mauro Gargiulo)
• 10:57–11:03 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Renal arteries complications in F/BEVAR (Alvaro Razuk)
• 11:03–11:09 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Strategies for shaggy aorta in open thoracic aortic surgery (Kay-Hyun Park)
• 11:09–11:15 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Inner vs. outer branches for complex aortic repair. Results of a multicenter study (Nikolaos Tsilimparis)
• 11:15–11:21 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Role of aortic arch debranching in the era of branched endografts (Muhammad Ali A. Rana)
• 11:21–11:27 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Dedication matters - durable bridging stents in FEVAR and BEVAR (Eric Verhoeven)
• 11:27–11:37 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Discussion
• 11:37–11:47 SESSION 15: THORACO-ABDOMINAL AORTIC ANEURYSM — Keynote Lecture: TAAA open surgery (in the endovascular era) (Joseph S. Coselli)
• 11:50–11:56 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — Early and mid-term results of thoraco-abdominal aneurysms and chronic dissections treated with a Brazilian fully repositionable and retrievable endograft (Arno von Ristow)
• 11:56–12:02 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — What do we know about the mid-term outcomes of the STABILISE technique? (Luís Mendes Pedro)
• 12:02–12:08 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — False lumen occlusion is becoming standard of care: long-term results from the international multicenter Candy-Plug Registry (Tilo Kölbel)
• 12:08–12:14 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — The influence of shape differences and aortic remodelling after aortic Type B dissections (Kak Khee Yeung)
• 12:14–12:20 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — Destiny of aortic branches after TEVAR in aortic dissection (Igor Koncar)
• 12:20–12:26 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — Why zone 2 TEVAR is preferred over zone 3 for acute Type B aortic dissection (Jean Panneton)
• 12:26–12:32 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — Spinal artery preservation after STABILISE: a multicentre analysis of patency and clinical implications (Alice Cabral Lopes)
• 12:32–12:40 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — Discussion
• 12:40–12:50 SESSION 16: AORTIC DISSECTION (STABILISE TECHNIQUE) — Keynote Lecture: STABILISE Registry (Germano Melissano)
• 12:50–13:20 Lunch
• 13:20–13:26 SESSION 17: AORTA — A new solution to an old challenge: off-the-shelf single-branch repair for Type A dissection (Ali Azizzadeh)
• 13:26–13:32 SESSION 17: AORTA — Longterm outcome data after EVAR underline need for lifelong surveillance (Dittmar Böckler)
• 13:32–13:38 SESSION 17: AORTA — Strategies to plan endografts for the long run and avoid regret (Bernardo Mendes)
• 13:38–13:44 SESSION 17: AORTA — Endovascular treatment of Type I endoleak after arch-branch (Tomasz Jakimowicz)
• 13:44–13:50 SESSION 17: AORTA — How to implement a physician modified program in your practice/institution (Young M. Erben)
• 13:50–13:56 SESSION 17: AORTA — Improving results on outpatient EVAR program (Alvaro Razuk)
• 13:56–14:02 SESSION 17: AORTA — PMEG - current status and future directions (Benjamin Starnes)
• 14:02–14:08 SESSION 17: AORTA — Real-world post market early outcomes of a new off-the-shelf thoraco-abdominal endoprosthesis: evidence, experience, and technical consideration (Steven Maximus)
• 14:08–14:14 SESSION 17: AORTA — How I do it: rescue strategies for failed EVAR (Fatima Javairiah)
• 14:14–14:25 SESSION 17: AORTA — Discussion
• 14:25–14:35 SESSION 17: AORTA — Keynote Lecture: The "Alfieri operation": 35 years from intuition to worldwide standard (Ottavio Alfieri, Francesco Maisano)
• 14:38–14:44 SESSION 18: AORTA GENETICS — Expanding role for endovascular treatment of complex aortic disease in genetically triggered aortic disease (Anders Wanhainen)
• 14:44–14:50 SESSION 18: AORTA GENETICS — Open surgery for heritable aortopathies (Joseph S. Coselli)
• 14:50–14:56 SESSION 18: AORTA GENETICS — Thoraco-abdominal aortic intervention as part of a multi-segment strategy for syndromic disease: the Liverpool Experience (Manoj Kuduvalli)
• 14:56–15:02 SESSION 18: AORTA GENETICS — Transcriptomics and new therapeutic hypothesis (Alessandro Pini)
• 15:02–15:08 SESSION 18: AORTA GENETICS — Is CILCA variant of genetic origin? (Annarita Santoro)
• 15:08–15:14 SESSION 18: AORTA GENETICS — Truth, lies, and statistics in endovascular therapy for Marfan's Syndrome (James Black)
• 15:14–15:20 SESSION 18: AORTA GENETICS — Discussion
• 15:20–15:30 SESSION 18: AORTA GENETICS — Keynote Lecture XV: The "new" enemy book of heritable aortopathies (John A. Elefteriades)
• 15:33–15:39 SESSION 19: VENOUS III — Iliac vein aneurysm: a rare circumstance with a curious ending (Mattia Mirandola)
• 15:39–15:45 SESSION 19: VENOUS III — Role of open reconstruction in venous outflow obstruction (Manj Gohel)
• 15:45–15:51 SESSION 19: VENOUS III — Update on new venous guidelines of the North-American Vascular Societies: what is new and what is controversial (Peter Gloviczki)
• 15:51–15:57 SESSION 19: VENOUS III — Who, when, and how to treat with symptomatic acute DVT: Getting the right strategy (Domenico Baccellieri)
• 15:57–16:03 SESSION 19: VENOUS III — Future is mechanical thrombectomy, paradigm change in endovascular acute DVT treatment (Mert Dumantepe)
• 16:03–16:09 SESSION 19: VENOUS III — New technology in vascular ultrasound field (Edoardo Cervi)
• 16:09–16:15 SESSION 19: VENOUS III — Clinical factors associated with iliac vein stent thrombosis (Enrico Ascher)
• 16:15–16:25 SESSION 19: VENOUS III — Discussion
• 16:25–16:35 SESSION 19: VENOUS III — Keynote Lecture (Stephen Black)
• 16:38–16:44 SESSION 20: INTERESTING VASCULAR TOPICS — Renal protection in complex aortic procedures (Diletta Loschi)
• 16:44–16:50 SESSION 20: INTERESTING VASCULAR TOPICS — Surgical management of vascular rings - How to do it? (Aung Oo)
• 16:50–16:56 SESSION 20: INTERESTING VASCULAR TOPICS — Role of vascular surgeons in cardiopulmonary emergencies (ECMO and pulmonary embolism) (Muhammad Ali A. Rana)
• 16:56–17:02 SESSION 20: INTERESTING VASCULAR TOPICS — Novel branched endograft for complex abdominal aortic aneurysms (Alexandre Araujo Pereira)
• 17:02–17:08 SESSION 20: INTERESTING VASCULAR TOPICS — State of the art treatment for acute mesenteric ischemia (Tayrine Mazotti)
• 17:08–17:14 SESSION 20: INTERESTING VASCULAR TOPICS — Importance of IVUS in aortic procedure (Wassim Mansour)
• 17:14–17:20 SESSION 20: INTERESTING VASCULAR TOPICS — Surgical treatment for midaortic syndrome: our experience (Beate Lindberg)
• 17:20–17:26 SESSION 20: INTERESTING VASCULAR TOPICS — VORTEC technique in dif ferent anatomical settings (Zoran Rancic)
• 17:26–17:50 SESSION 20: INTERESTING VASCULAR TOPICS — Discussion
• 17:50–18:00 SESSION 20: INTERESTING VASCULAR TOPICS — Keynote Lecture: Pragmatic follow-up schedule after EVAR and alternative treatment plans in case of failure (Michel S. Makaroun)

Friday, December 18th

December 18, 2026

• 07:30–08:10 SESSION 21: ROUND TABLE | UNMET NEEDS IN EVAR: NEXT STEPS FOR A REAL CONSOLIDATION — Round table discussion: Unmet needs in EVAR — next steps for a real consolidation — Panellists: Marian Broasca, Adelino Leite Moreira, Giuseppe Mazzotta, Stefano Pirrelli
• 08:13–08:19 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Our experience with the use of the Fiber Optic RealShape (FORS) Lumiguide technique for endovascular navigation during complex aortic procedures (Frederic Cochennec)
• 08:19–08:25 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — TOE vs ICE in aortic dissection as a guide in the aortic dissection procedures (Eustachio Agricola)
• 08:25–08:31 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Non-adhesive liquid embolic agents in different thoracic and abdominal diseases (Massimo Venturini)
• 08:31–08:37 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Trans caval approach for type 2 endoleak treatment (Gianpaolo Carrafiello)
• 08:37–08:43 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Value of PET/CT scans in detecting and treating vascular graft infections: what are their limitations (Zoran Rancic)
• 08:43–08:49 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Aortic length as a component in indicating infrarenal aortic disease processes (Martin Czerny)
• 08:49–08:55 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Advantages of photon counting CT in aortic imaging (Antonio Esposito)
• 08:55–09:02 SESSION 22: ADVANCEMENTS IN DIAGNOSIS — Discussion
• 09:05–09:11 SESSION 23: VENOUS IV — Robotic assisted nutcracker syndrome management (Young M. Erben)
• 09:11–09:17 SESSION 23: VENOUS IV — Treatment dtrategies for Type IV and Type V Chronic Venous Obstructions (Mert Dumantepe)
• 09:17–09:23 SESSION 23: VENOUS IV — Optimizing outcomes in acute iliofemoral DVT: the emerging role of computer-assisted vacuum thrombectomy (Efthymios Avgerinos)
• 09:23–09:29 SESSION 23: VENOUS IV — Venous thoracic outlet dyndrome, my practice and current evidence (Mert Dumantepe)
• 09:29–09:35 SESSION 23: VENOUS IV — Role of DCB treating vascular access stenosis (Matteo Tozzi)
• 09:35–09:41 SESSION 23: VENOUS IV — Midterm outcome of dedicated venous stent for treatment of central vein steno-occlusion in hemodialysis patients (Jimmy Wei Hwa Tan)
• 09:41–09:47 SESSION 23: VENOUS IV — Advanced lymphedema surgery: how I select, stage and perform reduction surgery in the modern era (Marald Wikkeling)
• 09:47–09:55 SESSION 23: VENOUS IV — Discussion
• 09:55–10:05 SESSION 23: VENOUS IV — Keynote Lecture: A systematic review and meta-analysis of the efficacy and safety of lytic and non-lytic early thrombus removal technologies for iliofemoral deep vein thrombosis (Stephen A. Black)
• 10:08–10:14 SESSION 24: TAAA — FEVAR using self-flared bridging stent (Giovanni Pratesi)
• 10:14–10:20 SESSION 24: TAAA — Should zone 2 landing be solved with branched devices? (Vicente Riambau)
• 10:20–10:26 SESSION 24: TAAA — Hole-y grail: mastering spot-on fenestrations in physician-modified (Csaba Csobay-Novák)
• 10:26–10:32 SESSION 24: TAAA — The impact of operator's learning curve on the outcomes of an off-the-shelf multi-branched endograft for complex and thoraco-abdominal aneurysms repair (Enrico Gallitto)
• 10:32–10:38 SESSION 24: TAAA — SVS clinical practice guidelines (Joseph V. Lombardi)
• 10:38–10:44 SESSION 24: TAAA — Technical difficulties and complications during the treatment of aortic arch aneurysms and dissections with branched prostheses (Marcelo Ferreira)
• 10:44–10:50 SESSION 24: TAAA — Left subclavian revascularisation: which endovascular strategy, and when? (Bijan Modarai)
• 10:50–11:00 SESSION 24: TAAA — Discussion
• 11:00–11:10 SESSION 24: TAAA — Keynote Lecture: How to avoid/treat complications of complex aortic endovascular procedures (Gustavo S. Oderich)
• 11:13–11:19 SESSION 25: ORGAN PROTECTION — Clinical experience on almost 500 MEP assessments (Michael J.H.M. Jacobs)
• 11:19–11:25 SESSION 25: ORGAN PROTECTION — Aortic arch replacement, ideas to facilitate thoraco-abdominal second stage (Emanuele Gatta)
• 11:25–11:31 SESSION 25: ORGAN PROTECTION — Perfusion strategy in open thoracoabdominal surgery with challenging access. What are the options? (Morad Sallam)
• 11:31–11:37 SESSION 25: ORGAN PROTECTION — Prevention of spinal cord ischemia after endovascular stent-graft repair of thoracic aorta (Pierfrancesco Veroux)
• 11:37–11:43 SESSION 25: ORGAN PROTECTION — Spinal cord ischemia in endovascular aortic repair: contemporary prevention strategies and clinical outcomes (Grace Mulatti)
• 11:43–11:49 SESSION 25: ORGAN PROTECTION — Endograft stiffness hurts the heart: "Robbing Peter to Pay Paul" (John A. Elefteriades)
• 11:49–11:55 SESSION 25: ORGAN PROTECTION — Organ protection in TAAA (Joseph S. Coselli)
• 11:55–12:01 SESSION 25: ORGAN PROTECTION — Prevention of spinal cord ischemia after endo TAAA reapir using patient-specific computational modelling (Barend Mees)
• 12:01–12:10 SESSION 25: ORGAN PROTECTION — Discussion
• 12:10–12:20 SESSION 25: ORGAN PROTECTION — Keynote Lecture: Cerebral protection during aortic arch surgery (Davide Pacini)
• 12:20–12:25 SESSION 25: ORGAN PROTECTION — Winners of the Young Investigators Competition (Andrea Kahlberg)
• 12:28–12:34 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — AI in planning, seizing and endoleak detection (Igor Koncar)
• 12:34–12:40 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — Benefit in AI for CBCT reconstruction (Stephan Haulon)
• 12:40–12:46 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — AI and biomechanics in AAA predictive analytics (Nathan L. Liang)
• 12:46–12:52 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — Deep learning-driven false-lumen volumes predict adverse remodeling better than diameter in patients with residual aortic dissection on CT (Mariangela De Masi)
• 12:52–12:58 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — From scalpel to sensor: how I integrate AI, telemonitoring and remote case support into daily vascular practice (Marald Wikkeling)
• 12:58–13:04 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — Visualization and comparison of hemodynamics in the native aorta and after branched endovascular repair using computational flow simulations (Fiona Rohlffs)
• 13:04–13:10 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — Digital twins in aortic disease: from concept to clinical decision tool (Bijan Modarai)
• 13:10–13:20 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — Discussion
• 13:20–13:30 SESSION 26: ARTIFICIAL INTELLIGENCE 2 — Keynote Lecture: Robotics in thoracic surgery (Giulia Veronesi)
• 13:30–14:00 Lunch
• 14:00–14:06 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Endovascular repair of ruptured abdominal aortic aneurysm (Felice Pecoraro)
• 14:06–14:12 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Open conversion of infected aortic endografts: data from a prospective, multicentre registry (Antonio Freyrie)
• 14:12–14:18 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Endovascular treatment of ruptured thoracic aneurysm - single center experience (Igor Koncar)
• 14:18–14:24 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — An enhanced recovery protocol for late open conversion after EVAR failure (Efrem Civilini)
• 14:24–14:30 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Improved outcomes of open repair of abdominal aneurysm rupture (Kay-Hyun Park)
• 14:30–14:36 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Addressing Type II endoleak after EVAR: an innovative strategy to improve stent-graft stability and reduce the risk of late aneurysm rupture (Rocco Giudice)
• 14:36–14:42 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — A decade of the GSTT aortic infection programme. Why we should focus more on management algorithm outcomes than comparing treatment options? (Morad Sallam)
• 14:42–14:50 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Discussion
• 14:50–15:00 SESSION 27: EVAR COMPLICATED/RUPTURED AAA — Keynote Lecture XXII: Impact of endovascular protocol adoption on ruptured aortic aneurysm outcomes: lessons learned from an institutional analysis (Grace Mulatti)
• 15:03–15:09 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — Mini-Incision carotid endarterectomy (Enrico Ascher)
• 15:09–15:15 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — Beyond dogma: strategy-driven stroke prevention in carotid revascularization (Stefano Bartoli)
• 15:15–15:21 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — Completion angiography after carotid endarterectomy is crucial (Dittmar Böckler)
• 15:21–15:27 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — Is it whortwhile treating carotid pseudoocclision? (Raffaele Pulli)
• 15:27–15:33 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — Impact of carotid revascularization on cognitive performance (Gianluca Faggioli)
• 15:33–15:39 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — CEA in very elderly patients: indications and AI potential role (Andrea Ascoli Marchetti)
• 15:39–15:47 SESSION 28: SUPRA-AORTIC / CAROTID ARTERIES — Discussion
• 15:50–15:56 SESSION 29: MORE ARTERIAL TOPICS — Femoral complications of percutaneous access: prevention and treatment (Diletta Loschi)
• 15:56–16:02 SESSION 29: MORE ARTERIAL TOPICS — Primary outcomes of a BTK sirolimus-eluting bioresorbable vascular scaffold for the treatment of infrapopliteal lesions (Michael Lichtenberg)
• 16:02–16:08 SESSION 29: MORE ARTERIAL TOPICS — Lessons from more than 650 CERAB cases in the BeGlory registry (Barend Mees)
• 16:08–16:14 SESSION 29: MORE ARTERIAL TOPICS — The semmelweis legacy: lessons learned applicable to vascular and wound care practices (Peter Gloviczki)
• 16:14–16:20 SESSION 29: MORE ARTERIAL TOPICS — Overcoming recoil in BTK interventions: tips and tricks (Jos C. van den Berg)
• 16:20–16:26 SESSION 29: MORE ARTERIAL TOPICS — The guidewire crosses but nothing else does. What to do? (Marta Lobato)
• 16:26–16:32 SESSION 29: MORE ARTERIAL TOPICS — Innovation in aortic arch and thoracic treatment: the role of the integrated CO2 protocol in reducing gas embolisms (Sara Speziali)
• 16:32–16:38 SESSION 29: MORE ARTERIAL TOPICS — Drug eluting stent in femoropopliteal disease: real-world evidence from a single-center experience (Alessia Giaquinta)
• 16:38–16:45 SESSION 29: MORE ARTERIAL TOPICS — Discussion
• 16:45–16:55 SESSION 29: MORE ARTERIAL TOPICS — Keynote Lecture: Innovative open and endovascular techniques developed over the years to save hopelessly ischemic lower limbs (Enrico Ascher)
• 16:58–17:04 SESSION 30: VENOUS V — Stenting for left renal vein compression (Rabih Chaer)
• 17:04–17:10 SESSION 30: VENOUS V — Venous stenting in oncology patients (Efthymios Avgerinos)
• 17:10–17:16 SESSION 30: VENOUS V — Twenty years of clinical experience with radiofrequency ablation: evidence, outcomes, and current (Chiara Lomazzi)
• 17:16–17:22 SESSION 30: VENOUS V — Mechanical thrombectomy for iliofemoral DVT treatment – current technology (Michael Lichtenberg)
• 17:22–17:28 SESSION 30: VENOUS V — Outcome of stent graft treatment in the central vein stenosis (Matteo Tozzi)
• 17:28–17:34 SESSION 30: VENOUS V — Our experience in the management renal tumors with vena cava involvement requiring hepatic vascular exclusion (Frederic Cochennec)
• 17:34–17:40 SESSION 30: VENOUS V — Innovation in stent design applied to ilio-caval reconstruction (Domenico Baccellieri)
• 17:40–17:46 SESSION 30: VENOUS V — Cyanoacrylate glue venous truncal ablation – how I do it and 5 year results (Kevin Cassar)
• 17:46–17:55 SESSION 30: VENOUS V — Discussion
• 17:55–18:05 SESSION 30: VENOUS V — Keynote Lecture: Complex surgery of the deep veins (Peter Gloviczki)
• 18:08–18:14 SESSION 31: FLOW LIMITED ILIAC ARTERY (FLIA) — Thermography for screening (Paolo Raugei)
• 18:14–18:20 SESSION 31: FLOW LIMITED ILIAC ARTERY (FLIA) — Open surgery for iliac artery (Daniele Mascia)
• 18:20–18:26 SESSION 31: FLOW LIMITED ILIAC ARTERY (FLIA) — Redo surgery can bring an Olympic gold (Laurent Chiche)
• 18:26–18:32 SESSION 31: FLOW LIMITED ILIAC ARTERY (FLIA) — Discussion
• 18:35–18:41 SESSION 32: AORTA — Managing aortic complexity with a new off-the-shelf thoraco-abdominal: evidence, experience, and technical consideration (Nathan Lang)
• 18:41–18:47 SESSION 32: AORTA — Aneurysm sac dynamics and its prognostic significance following fenestrated and branched endovascular aortic aneurysm repair (Sonia Ronchey)
• 18:47–18:53 SESSION 32: AORTA — From standardization to results: AI in 4-fen PMEG and SPHERE Registry Data (Michele Piazza)
• 18:53–18:59 SESSION 32: AORTA — Physician-modified and in situ fenestration for visceral aorta repair: combine techniques to overcome challenges (Martina Bastianon)
• 18:59–19:05 SESSION 32: AORTA — Quadruple arch-branch in patients with arteria lusoria (Tomasz Jakimowicz)
• 19:05–19:11 SESSION 32: AORTA — Physician modification of commercially available devices to replicate the frozen elephant trunk tecnique (Enrico Rinaldi)
• 19:11–19:17 SESSION 32: AORTA — Open conversion after failed EVAR is increasing and associated with better survival and reintervention rates to F/B FEVAR (George Geroulakos)
• 19:17–19:23 SESSION 32: AORTA — How we approach complex aortic repair in Brazil (Julio Plecat)
• 19:23–19:29 SESSION 32: AORTA — Complex Aortic Aneurysm Repair: the current status in South Africa (James Tunnicliffe)
• 19:29–19:35 SESSION 32: AORTA — PMEG in resources limited settings (Mohamed Hosny)
• 19:35–19:41 SESSION 32: AORTA — Techniques for the treatment of hostile necks during EVAR (Aaron Fargion)
• 19:41–19:50 SESSION 32: AORTA — Discussion
• 19:50–20:00 Closing Remarks